Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors, Primitive, Peripheral

Explore clinical trials studying Neuroectodermal Tumors, Primitive, Peripheral. Study availability and eligibility vary by location and protocol.

501 public trials 99 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive, Peripheral trial results

Active, Not Recruiting

Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)

NCT04385277

Conditions
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, Neoplasms, +9 more
Locations
  • Banner Children's at Desert Mesa, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 77 locations
View Trial Details
Active, Not Recruiting

Parental Decision-Making for Children With Relapsed Neuroblastoma

NCT02282735

Conditions
Death, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Stanford/Packard's Children's Hospital Palo Alto, California, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions